From September 28 to 29, bic2021 - the third Asian biopharmaceutical Innovation Summit was successfully held in Shanghai. Union Biotechbiological took part in the "Third Asian biopharmaceutical Innovation Summit (bic2021)" with the company's product line equipment and received extensive attention. The summit focused on innovative research and development and production processes of biological drugs, and reviewed and prospected the development and production technologies of biological products such as antibody coupled drugs (ADC), double antibodies, car-t, AAV, gene and cell therapy, IPSC stem cell therapy, oncolytic virus therapy, innovative vaccines and mRNA coronavirus vaccines under the institutional innovation of MAH and ICH.

Bic2021 invited more than 1000 industry experts to the site for exchange. Leading enterprises from the industry shared the latest technology platforms and solutions. The summit provided an efficient platform for business negotiation, technology sharing, product display and release for the development of biopharmaceutical industry

As the main exhibitor invited by the conference, Union-Biotech showed a series of products, equipment and consumables including cell culture medium, insect culture medium, high-pressure cell crusher, protein purifier and so on at this exhibition, which has attracted extensive attention.

As an innovative enterprise in life science and technology, Union-Biotech (Shanghai) Co., Ltd. has been deeply engaged in the field of cells for 20 years and has accumulated strong strength in the research and development of biomedical professional instruments, biomaterials and biological reagents. Union-Biotech continues to research and participate in the discussion of experts and scholars, is committed to creating a line of products with full coverage of protein research, and launch more products suitable for professional customers with higher cost performance, so as to play a greater role in improving people's health

2021-9-29

Union Marketing Department